AXA Framlington Health Fund Z INC

AXA Framlington Health Fund Z INC
AXA Investment Managers UK Ltd
Unit Trust
0.82 %
Risk Rating
3 Year Sharpe
3 Year Alpha
0.2 %
MSCI World/Health Care GR USD
The aim of this Fund is to provide long-term capital growth. The Fund invests in shares of listed healthcare companies including producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world albeit the Fund tends to be biased towards the US, as this is where the majority of healthcare related companies are based. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.
Holding %
Merck & Co Inc 6.27 %
GlaxoSmithKline PLC 4.41 %
Medtronic PLC 4.34 %
Thermo Fisher Scientific Inc 4.30 %
Anthem Inc 3.79 %
UnitedHealth Group Inc 3.51 %
Alexion Pharmaceuticals Inc 3.36 %
Allergan PLC 3.17 %
Takeda Pharmaceutical Co Ltd 3.13 %
Eli Lilly and Co 2.89 %
Region %
United States 76.49 %
Eurozone 7.92 %
United Kingdom 6.97 %
Japan 5.25 %
Sector %
Healthcare 95.62 %
AXA Investment Managers UK Ltd
EC1A 7NX, London, United Kingdom
Legal Structure
Unit Trust


Dani Saurymper
Joined 04/30/2016

Dani Saurymper joined AXA IM in April 2015 as Fund Manager for the AXA Framlington Health Fund. He joined from Barclays Capital where he was a senior equity research analyst covering European healthcare.

Data provided by Morningstar.

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.